Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELIMINATE: Influenza Vaccination After Myocardial Infarction
NCT06336317Phase 4Recruiting
- Sponsor
- Region Örebro län
- Start
- Apr 2024
- Primary completion
- Dec 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
Phase 4, randomised, double-blind trial of influenza vaccine in acute myocardial infarction (AMI) (2 arms), sponsored by Region Örebro län. Primary endpoint: Inflammation in the right coronary artery measured by CCTA at 8 weeks. Started Apr 2024; status: recruiting.
02
Drugs
influenza vaccine
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT06336317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06336317.